https://www.pharmanow.live/latest-news/abbvie-phase-2a-dual-targeting-crohns-remission-rates 2026-10-21T23:42:56+05:30 Pharma Now en 2026-10-21T00:00:00+05:30 AbbVie Achieves Higher Remission Rates in Phase 2a Dual-Targeting Crohn's Disease Trial AbbVie https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/cf69b07d-47d1-4a07-8b92-b0e3a7aabc0a/f109b9ed-d023-4f31-b122-c5775e899d39.png https://www.pharmanow.live/latest-news/dr-reddys-dcgi-approval-zytorvi-esophageal-cancer 2026-10-21T23:44:11+05:30 Pharma Now en 2026-10-21T00:00:00+05:30 Dr. Reddy's Gains DCGI Approval for Zytorvi in Advanced Esophageal Cancer Indication Dr. Reddy's https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/cf69b07d-47d1-4a07-8b92-b0e3a7aabc0a/4c102099-a6cb-4f4f-a1c8-692d6cfa037b.png https://www.pharmanow.live/latest-news/achieve-life-sciences-52-week-cytisinicline-orca-ol-chest-2026 2026-10-22T12:33:59+05:30 Pharma Now en 2026-10-21T00:00:00+05:30 Achieve Reports 52-Week Cytisinicline Results at CHEST 2026 Achieve https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/achieve-cytisinicline-52-week-orca-ol-smoking-vaping-cessation-202620261022123348.webp https://www.pharmanow.live/latest-news/astrazeneca-oracle-ai-partnership-clinical-trials-early-diagnosis 2026-10-22T12:29:38+05:30 Pharma Now en 2026-10-21T00:00:00+05:30 AstraZeneca-Oracle AI Partnership Targets Faster Clinical Trials AstraZeneca-Oracle https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/astrazeneca-oracle-ai-clinical-trials-early-diagnosis-202620261022122846.webp https://www.pharmanow.live/latest-news/sutro-biopharma-first-patient-dosed-stro-006-itgb6-adc-phase-1-trial 2026-10-22T12:13:27+05:30 Pharma Now en 2026-10-21T00:00:00+05:30 Sutro Biopharma Doses First Patient in Phase 1 STRO-006 Trial Sutro https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/sutro-stro-006-phase-1-itgb6-adc-first-patient-dose-202620261022121154.webp https://www.pharmanow.live/latest-news/unicycive-fda-acceptance-olc-nda-resubmission-pdufa-march-2027 2026-10-22T12:07:55+05:30 Pharma Now en 2026-10-21T00:00:00+05:30 Unicycive Gains FDA Acceptance for OLC NDA Resubmission Unicycive https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/unicycive-fda-olc-nda-resubmission-pdufa-march-2027-202620261022120746.webp https://www.pharmanow.live/latest-news/abbott-separates-nutrition-business-independent-company-2027 2026-10-22T12:03:22+05:30 Pharma Now en 2026-10-21T00:00:00+05:30 Abbott Plans to Spin Off Its $8.5B Nutrition Business by 2027 Abbott https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/abbott-nutrition-business-spin-off-independent-company-202720261022120229.webp https://www.pharmanow.live/latest-news/olympus-import-alert-quality-system-regulation-violations-japan-2026 2026-10-22T11:58:49+05:30 Pharma Now en 2026-10-21T00:00:00+05:30 Olympus Faces FDA Import Alert Over Quality System Violations Olympus https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/olympus-fda-import-alert-quality-system-violations-japan-202620261022115645.webp https://www.pharmanow.live/latest-news/genentech-gains-regular-fda-approval-pralsetinib-ret-fusion-positive-nsclc 2026-10-22T11:51:28+05:30 Pharma Now en 2026-10-21T00:00:00+05:30 Genentech Secures Regular FDA Approval for Pralsetinib Genentech https://www.pharmanow.live/latest-news/telix-pharmaceuticals-pixclara-fda-approval-itm-merger-q3-2026 2026-10-22T11:45:26+05:30 Pharma Now en 2026-10-21T00:00:00+05:30 Telix Wins FDA Approval for Pixclara and Announces ITM Merger Telix https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/telix-pixclara-fda-approval-itm-merger-q3-202620261022114422.webp https://www.pharmanow.live/latest-news/fda-finalizes-prescription-drug-use-related-software-guidance 2026-10-22T11:41:34+05:30 Pharma Now en 2026-10-21T00:00:00+05:30 FDA Finalizes Guidance on Prescription Drug-Related Software FDA https://www.pharmanow.live/latest-news/fda-launches-nonprescription-drug-stakeholder-engagement-plan-rx-to-otc-switch 2026-10-22T11:30:23+05:30 Pharma Now en 2026-10-21T00:00:00+05:30 FDA Launches Plan to Expand Nonprescription Drug Access FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-nonprescription-drug-stakeholder-engagement-rx-to-otc-switch-202620261022112805.webp https://www.pharmanow.live/latest-news/gsk-fda-approval-hibsago-first-aso-chronic-hepatitis-b 2026-10-22T11:24:22+05:30 Pharma Now en 2026-10-21T00:00:00+05:30 GSK Wins FDA Approval for Hibsago in Chronic Hepatitis B GSK https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/gsk-hibsago-fda-approval-first-aso-chronic-hepatitis-b-202620261022112329.webp https://www.pharmanow.live/latest-news/zydus-pharmaceuticals-fda-approval-generic-estradiol-levonorgestrel-transdermal-patch 2026-10-22T11:20:45+05:30 Pharma Now en 2026-10-21T00:00:00+05:30 Zydus Wins FDA Approval for First Generic Climara Pro Patch Zydus https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/zydus-fda-approval-generic-climara-pro-estradiol-levonorgestrel-patch-202620261022111812.webp https://www.pharmanow.live/latest-news/baxter-international-fda-warning-letter-cephalosporin-cross-contamination-round-lake 2026-10-22T11:15:07+05:30 Pharma Now en 2026-10-21T00:00:00+05:30 Baxter Receives FDA Warning Letter Over CGMP Violations Baxter https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/baxter-fda-warning-letter-cephalosporin-cross-contamination-cgmp-202620261022111056.webp https://www.pharmanow.live/latest-news/rohto-pharmaceutical-fda-warning-letter-vietnam-cgmp-violations-2026 2026-10-22T11:03:27+05:30 Pharma Now en 2026-10-21T00:00:00+05:30 Rohto Receives FDA Warning Letter for Vietnam CGMP Failures Rohto https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/rohto-pharmaceutical-fda-warning-letter-vietnam-cgmp-failures-202620261022105748.webp